Background: Clinical laboratory testing is an integral part of patient care. Many factors influence haematological parameters and it is pivotal for individual laboratories to establish own reference intervals. Aims: To determine reference intervals for haematology parameters and iron studies markers. Methods: 255 healthy blood donors (132 males and 123 females) were recruited. The haematology parameters were analysed by haematology analysers, serum iron, transferrin and soluble serum transferrin receptor (sTfR) were determined spectrophotometrically while serum ferritin was measured using chemiluminescence method.
IRON INCLUSIONS IN PLASMA CELLS
Archna Sharma, Tracey Batt and Anna Johnston Department of Haematology, Royal Hobart Hospital, Hobart, Tas, Australia Copper deficiency is a rare cause of pancytopenia. We report findings in a 26-year-old female with history of Wilson'^ disease diagnosed 13 years previously who was found to be pancytopenic. She was admitted for replacement of a muscle relaxant (baclofen) pump. Full blood examination showed haemoglobin 73 g/L, MCV 90 fl, MCH 26 pg, WCC 1.5 x 109/L, neutrophils 0.7 x 109/L and platelet count 115 x 109/L. Bone marrow examination revealed a normocellular marrow with dyserythropoeisis, sequential myeloid maturation and increased megakaryocytes. Erythroid and myeloid precursors showed vacuoles in the cytoplasm. There were prominent iron positive inclusions in the plasma cells in the iron stain.
The bone marrow findings seen in this patient have been classically described in copper deficiency. One of the treatment modalities in Wilson's disease is zinc therapy to prevent absorption of copper. The patient was on long term Zinc supplementation (220 mg three times a day). Her serum zinc level was 19.2umol/L, serum copper 0.1 |xmol/L and ceruloplasmin 0.02 g/L. While zinc supplementation can be an effective treatment for Wilson's disease, overtreatment can induce copper deficiency leading to cytopenias with characteristic bone marrow appearance. Recognition is important as copper deficiency can be associated with neurological deterioration due to peripheral neuropathy. A large number of RIs were reported, but many did not significantly differ. Different RIs were reported for the same instruments, and most were derived from published material. Wide ranges were reported for UM. The definition of adult versus paediatric varied, with 60% of respondents using a cut-off of 14 years and the remainder using 18 years.
A SURVEY OF AUSTRALIAN RED CELL REFERENCE INTERVALS

Discussion:
We have demonstrated a wide range of RIs currently reported by Australian laboratories even though the actual numerical differences seem to fall within the uncertainty of the measured parameters. These ranges are statistically similar in many cases, suggesting harmonisation of haematology RIs could be considered. We present a case report of a 49-year-old female with recently diagnosed chronic myeloid leukaemia, in chronic phase (CML-CP), presenting 10 days following commencement of imatinib with fevers, generalised rash, oedema, and systemic inflammatory response syndrome (SIRS) mimicking severe sepsis. Skin punch biopsy was compatible with drug reaction, with findings consistent with urticarial vasculitis. Although dermatological toxicities have been associated with imatinib, isolated cutaneous urticarial vasculitis with associated severe SIRS has never been reported in the literature. Rapid clinical resolution following the use of corticosteroid and cessation of imatinib in this patient strongly suggests the causative role of imatinib. Her higher initiation dose of 600 mg
URTICARIAL VASCULITIS IN ASSOCIATION WITH
